Oxford Covid-19 vaccine prompts immune response in young and old adults: AstraZeneca

One of the world’s leading Covid-19 experimental vaccines produces a immune response in both young and old adults, raising hopes of a path out of the gloom and economic destruction wrought by the novel coronavirus.The vaccine, developed by the University of Oxford, also triggers lower adverse responses among the elderly, British drug maker AstraZeneca Plc, which is helping manufacture the vaccine, said on Monday.A vaccine that works is seen as a game-changer in the battle against the novel…